This medical equipment company develops sensory technology for prosthetic limbs to alleviate Phantom Limb Syndrome (PLS) symptoms in amputees. Their platform enables users to experience sensations on their prosthetic limb, fostering a more natural and integrated body-brain-prosthetic connection.
Funding
$995K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Amputees often experience phantom limb syndrome (PLS) and residual limb pain (RLP), leading to depression, opioid dependence, and suicidal tendencies. Current pain management solutions may rely on pharmaceuticals or invasive procedures with undesirable side effects.
Solution
NeuroX Innovations develops wearable neuromodulation technology to provide non-pharmaceutical pain management for amputees. Their device targets the nervous system to reduce pain at its source, aiming to alleviate PLS and RLP symptoms. By enabling communication between the body, brain, and prosthetic limb, NeuroX seeks to foster a more natural connection and improve the user's quality of life. The technology is designed for seamless integration into daily life, offering a comfortable and easy-to-use solution for chronic pain relief.
Target Audience
The primary target audience includes amputees experiencing phantom limb syndrome (PLS) and residual limb pain (RLP) seeking non-pharmaceutical pain management solutions.
Features
- Wearable device utilizing neuromodulation technology
- Non-pharmaceutical pain management
- Targets the nervous system to reduce pain at its source
- Aims to reduce symptoms of Phantom Limb Syndrome (PLS) and Residual Limb Pain (RLP)
- Designed for comfortable and easy integration into daily life